WO2003007948A1 - Antipaludique contenant un compose de rhodacyanine - Google Patents
Antipaludique contenant un compose de rhodacyanine Download PDFInfo
- Publication number
- WO2003007948A1 WO2003007948A1 PCT/JP2002/007255 JP0207255W WO03007948A1 WO 2003007948 A1 WO2003007948 A1 WO 2003007948A1 JP 0207255 W JP0207255 W JP 0207255W WO 03007948 A1 WO03007948 A1 WO 03007948A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- ion
- methyl
- antimalarial
- dye compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the F28-7 strain a wild strain of mouse breast cancer-derived FM3A cells, was used.
- Medium was added to a 2% fetal calf serum inactivated in ES medium, C ⁇ 2 concentration of 5% were cultured at 3 7 ° C.
- the doubling time of FM3A cells under these conditions was about 12 hours.
- Preculture was performed, and cells that had entered the logarithmic growth phase were diluted with a medium so as to have a concentration of 5 ⁇ 10 4 ce 11 s ZmL, and a sample prepared at the time of measuring the malaria activity was used.
- the sample solution prepared in Example 7 was added to a 24-well culture plate in an amount of 5 to 10 ⁇ L each. Two to three tests were performed for each test sample.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La présente invention concerne un antipaludique efficace contre le plasmode paludéen présentant une résistance a divers antipaludiques et ayant des effets secondaires réduits. L'antipaludique contient en tant que principe actif un composé de rhodacyanine de formule (I), dans laquelle: R1 et R2 représentent indépendamment hydrogène, alkyle en C¿1?-C8 substitué ou non substitué, ou aryle en C6-C8 ou R?1 et R2¿ sont liés l'un à l'autre pour former un noyau à six chaînons substitué ou non substitué; B représente un système conjugué; n est 0, 1 ou 2; A représente un groupe nécessaire à la formation d'un hétérocycle à cinq ou six chaînons, pouvant être non substitué ou ayant un ou des substituants, qui peuvent être liés l'un à l'autre; et Q représente un anion pharmaceutiqement acceptable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-220579 | 2001-07-19 | ||
JP2001220579A JP2003034641A (ja) | 2001-07-19 | 2001-07-19 | ロダシアニン系色素化合物を含有する抗マラリア剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003007948A1 true WO2003007948A1 (fr) | 2003-01-30 |
Family
ID=19054378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/007255 WO2003007948A1 (fr) | 2001-07-19 | 2002-07-17 | Antipaludique contenant un compose de rhodacyanine |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2003034641A (fr) |
WO (1) | WO2003007948A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1800682A1 (fr) * | 2004-10-04 | 2007-06-27 | Japan Science and Technology Agency | Préparation médicamenteuse pour le traitement prophylactique ou thérapeutique d une infection protozoaire parasitaire |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004331545A (ja) * | 2003-05-06 | 2004-11-25 | Japan Science & Technology Agency | 抗リーシュマニア剤 |
JP4553354B2 (ja) | 2004-10-04 | 2010-09-29 | 正隆 井原 | 抗トリパノソーマ剤 |
JPWO2006137258A1 (ja) * | 2005-06-24 | 2009-01-08 | 独立行政法人科学技術振興機構 | アザロダシアニン化合物を有効成分として含有する医薬組成物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5360803A (en) * | 1991-08-13 | 1994-11-01 | Dan Farber Cancer Institute | Composition and method for treating cancer |
JPH0859467A (ja) * | 1994-08-18 | 1996-03-05 | Fuji Photo Film Co Ltd | 皮膚疾患治療薬 |
JP2000191531A (ja) * | 1998-12-28 | 2000-07-11 | Fuji Photo Film Co Ltd | 抗マラリア剤 |
-
2001
- 2001-07-19 JP JP2001220579A patent/JP2003034641A/ja active Pending
-
2002
- 2002-07-17 WO PCT/JP2002/007255 patent/WO2003007948A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5360803A (en) * | 1991-08-13 | 1994-11-01 | Dan Farber Cancer Institute | Composition and method for treating cancer |
JPH0859467A (ja) * | 1994-08-18 | 1996-03-05 | Fuji Photo Film Co Ltd | 皮膚疾患治療薬 |
JP2000191531A (ja) * | 1998-12-28 | 2000-07-11 | Fuji Photo Film Co Ltd | 抗マラリア剤 |
Non-Patent Citations (1)
Title |
---|
KIYOSEI TAKASU ET AL.: "Rhodacyanine dyes as antimalarials. 1. Preliminary evaluation of their activity and toxicity", J. MED. CHEM., vol. 45, no. 5, 2002, pages 995 - 998, XP002957612 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1800682A1 (fr) * | 2004-10-04 | 2007-06-27 | Japan Science and Technology Agency | Préparation médicamenteuse pour le traitement prophylactique ou thérapeutique d une infection protozoaire parasitaire |
EP1800682A4 (fr) * | 2004-10-04 | 2010-06-30 | Masataka Ihara | Préparation médicamenteuse pour le traitement prophylactique ou thérapeutique d une infection protozoaire parasitaire |
US8193224B2 (en) | 2004-10-04 | 2012-06-05 | Fujifilm Corporation | Medicinal composition for prevention or treatment of parasitic protozoan infection |
Also Published As
Publication number | Publication date |
---|---|
JP2003034641A (ja) | 2003-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10710987B2 (en) | Hydrochloride salt form for EZH2 inhibition | |
US7119104B2 (en) | Activator of peroxisome proliferator-activated receptor delta | |
ES2442907T3 (es) | Tiazolil dihidropirimidinas sustituidas con bromo-fenilo | |
EA008865B1 (ru) | Производные 2-имино-4-оксотиазолидина | |
US10077258B2 (en) | Substituted pyrimidine compounds as phosphatidylinositol 3-kinase delta inhibitor and use thereof | |
CN109535176B (zh) | 喹诺酮咪唑类化合物及其制备方法和应用 | |
EP2919779A1 (fr) | Composés pour la médiation d'un récepteur des cannabinoïdes | |
CN111601788A (zh) | 衣壳蛋白装配抑制剂、其药物组合物和用途 | |
US9403814B2 (en) | Crystalline forms of dihydropyrimidine derivatives | |
JP6610975B2 (ja) | 複素環イミダゾール類化合物、その医薬組成物及びその調製方法と用途 | |
WO2003007948A1 (fr) | Antipaludique contenant un compose de rhodacyanine | |
JP2004144526A (ja) | マラリア感染診断剤及びマラリア原虫染色剤 | |
JP2004331545A (ja) | 抗リーシュマニア剤 | |
CN102086212B (zh) | 抗真菌剂-2,3,4,5-四氢-4H-苯并[b]噻喃并[4,3-c]吡唑-2-甲酰胺衍生物 | |
JP2003034640A (ja) | 四環性複素化合物を含有する抗マラリア剤 | |
WO2001052849A1 (fr) | Remedes contre le diabete | |
JP2018087173A (ja) | 悪性脳腫瘍治療薬 | |
JP2003034642A (ja) | ロダシアニン色素化合物を含有する抗マラリア剤 | |
TWI811901B (zh) | 一種嘧啶甲醯胺類化合物及其應用 | |
CN114957216B (zh) | 靶点抑制剂及其制备方法、应用和药物组合物 | |
US9737510B2 (en) | Indazole compounds and a process for the preparation thereof | |
US20220378748A1 (en) | Use of Heterocyclic Derivatives with Cardiomyocyte Proliferation Activity for Treatment of Heart Diseases | |
US7105511B2 (en) | Fluorescent fused-ring triazoles that inhibit cell proliferation and uses thereof | |
US20190092756A1 (en) | Crystalline form a of 2-[(2r)-2-methyl-2-pyrrolidyl]-1h-benzimidazole-7-carboxamide dihydrochloride and preparation method thereof | |
CN102101857B (zh) | 一种抗真菌剂1-(4-氯-2H-苯并[b]噻喃-3-甲醛)缩氨基(硫)脲衍生物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |